Daiichi Sankyo Attacks Apotex Over Evoxac ANDA

Law360, New York (June 29, 2009, 12:00 AM EDT) -- Daiichi Sankyo Co. Ltd. has sued Apotex Inc. over the generic-drug maker's attempt to introduce its own version of Evoxac, a drug used to treat symptoms of dry mouth in patients with Sjogren's syndrome.

The Japanese drugmaker and its U.S. unit lodged their complaint Friday in the U.S. District Court for the District of Delaware, alleging that an abbreviated new drug application filed by Apotex infringes a Daiichi Sankyo patent.

As many as 4 million Americans currently have Sjogren's, a chronic autoimmune disease in which a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.